August 20, 2026
Announcing expansion of capabilities to provide customers with a broader range of DNA synthesis solutions, allowing IDT to complement and extend its market position in minimum residual disease (MRD) and multi-cancer early detection (MCED) research to support high-diversity assays Builds on nearly 40 years of synthesis experience to give customers rapid turnaround of high-diversity oligonucleotides and a [...]
August 20, 2026
The Salvus PFAS solution can screen up to seven samples per eight-hour shift so teams can act sooner at the point of concern. VALDOSTA, Ga. -- Salvus, LLC, released its first commercial-ready rapid screening solution for per- and polyfluoroalkyl substances (PFAS). The portable Salvus® PFAS solution enables teams to extract, concentrate, and screen samples at [...]
August 20, 2026
SAN FRANCISCO -- Benchling today announced its expansion into chemistry, bringing chemistry and biology together on one connected platform for scientific research and development. As part of this expansion, Benchling is launching Reactions, a new capability for planning and modeling single-step synthesis, and adding predictive models for small molecule R&D from Inductive Bio. For more than [...]
Albert Launches First Chemistry-Native AI Built for Enterprise R&D
August 20, 2026
Ask Albert instantly surfaces institutional knowledge and executes the research tasks that slow scientists down. OAKLAND, Calif. -- Albert today announced Ask Albert, agentic chemistry-native AI built for enterprise R&D, designed to surface scientific knowledge and execute research tasks with the accuracy and security enterprise chemical companies require. For decades, R&D organizations have accumulated vast scientific [...]
BactoScan™ 5 approved by MicroVal and NCIMS/FDA
August 19, 2026
The FOSS BactoScan™ 5, a rapid method for testing total bacteria count in raw milk, is now approved by MicroVal in Europe and NCIMS/FDA in the United States. Here is what the approvals cover - and what they mean for central milk testing laboratories, dairies, and producers. The National Conference on Interstate Milk Shipments (NCIMS), [...]
Solstice Introduces High-Purity Chromasolv™ LC-MS Solvents for PFAS Analysis
August 19, 2026
New methanol, water and acetonitrile solvents with more than 99.9% purity help laboratories reduce the risk of false or misleading results in sensitive PFAS testing MORRIS PLAINS, N.J. – Solstice Advanced Materials (NASDAQ: SOLS), a global leader in high-performance specialty materials, today announced the launch of high-purity Chromasolv™ LC-MS solvents for per‑ and polyfluoroalkyl substances (PFAS) [...]
Patented device reinvents Solid Phase Extraction
August 19, 2026
Biotech Fluidics announce SPEedy™ - a device that provides an effortless way to perform Solid Phase Extraction (SPE) sample preparation procedures without need of an external vacuum and compatible with any adsorption chemistry or eluent composition. Small enough to fit in your lab coat pocket, yet so powerful it will accomplish complete SPE procedures within minutes. The innovative design [...]
August 19, 2026
New APIs extend Wiley's gold-standard spectral data and analytical intelligence directly into lab, vendor, and platform workflows image: Wiley API Spectral Search HOBOKEN, NJ—Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence, today announced the launch of its spectral analysis application programming interface (API) portfolio, providing users with a new, faster way to [...]
Complete Genomics Appoints Lauren Selig to Board of Directors
August 19, 2026
SAN JOSE, Calif. — Complete Genomics, a U.S.-based provider of end-to-end DNA sequencing platforms, reagents and software, today announced the appointment of entrepreneur, investor and film producer Lauren Selig to its board of directors. Selig is the founder of Shake and Bake Productions and leads an investment fund focused on companies across artificial intelligence, space, biotechnology, media and other [...]
BioSkryb Genomics Names William E. Evans, Pharm.D. as Chief Executive Officer
August 19, 2026
Veteran Pharmacogenomics Leader and Former St. Jude CEO to Guide BioSkryb's Next Phase of Growth DURHAM, N.C. -- BioSkryb Genomics, a pioneer in single-cell and ultra-low-input multiomic solutions, today announced that William E. Evans, Pharm.D., has been appointed as Chief Executive Officer. Dr. Evans has served on BioSkryb's Board of Directors and as Chair of [...]

